Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Fformat: Journal article
Iaith:English
Cyhoeddwyd: 2012

Eitemau Tebyg